Septerna Common StockNASDAQ: SEPN

Profile

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

Next earnings report:

N/A

Last dividends:

N/A

Next dividends:

N/A
$752.47 M
-4%vs. 3y high
70%vs. sector
-vs. 3y high
-vs. sector
-11.10
-1%vs. 3y high
4%vs. sector
-vs. 3y high
-vs. sector

Price

regular market | Wed, 30 Oct 2024 13:30:00 GMT
$20.37+$0.35(+1.75%)

Dividend

No data over the past 3 years
No data over the past 3 years
No data over the past 3 years
No data over the past 3 years

Analysts recommendations

Institutional Ownership

Included in screeners

No data

SEPN Latest News

Septerna Announces Closing of $331.2 Million Upsized Initial Public Offering
globenewswire.com30 October 2024 Sentiment: POSITIVE

SOUTH SAN FRANCISCO, Calif., Oct. 30, 2024 (GLOBE NEWSWIRE) -- Septerna, Inc. (Nasdaq: SEPN), a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) oral small molecule drug discovery, today announced the closing of its upsized initial public offering (IPO) of 18,400,000 shares of its common stock at a public offering price of $18.00 per share, which includes an additional 2,400,000 shares issued upon the full exercise by the underwriters of their option to purchase additional shares. All of the shares were offered by Septerna.

What type of business is Septerna Common Stock?

Septerna, Inc., a clinical-stage biotechnology company, discovers and develops G protein-coupled receptor (GPCR) oral small molecule products candidates for the treatment of endocrinology, immunology and inflammation, and metabolic diseases. The company develops SEP-786, an oral small molecule PTH1R agonist for hypoparathyroidism; SEP-631, an oral small molecule MRGPRX2 NAM for chronic spontaneous urticaria and other mast cell diseases; TSHR Program, an oral small molecule TSHR NAM for Graves' disease and thyroid eye disease. It also develops oral small molecule single- and multi-incretin receptor agonists for metabolic disorders including obesity and type 2 diabetes. Septerna, Inc. was formerly known as GPCR NewCo, Inc. and changed its name to Septerna Inc. in June 2021. The company was incorporated in 2019 and is headquartered in South San Francisco, California.

What sector is Septerna Common Stock in?

Septerna Common Stock is in the Healthcare sector

What industry is Septerna Common Stock in?

Septerna Common Stock is in the Biotechnology industry

What country is Septerna Common Stock from?

Septerna Common Stock is headquartered in United States

What is Septerna Common Stock website?

https://septerna.com

Is Septerna Common Stock in the S&P 500?

No, Septerna Common Stock is not included in the S&P 500 index

Is Septerna Common Stock in the NASDAQ 100?

No, Septerna Common Stock is not included in the NASDAQ 100 index

Is Septerna Common Stock in the Dow Jones?

No, Septerna Common Stock is not included in the Dow Jones index

When was Septerna Common Stock the previous earnings report?

No data

When does Septerna Common Stock earnings report?

Next earnings report date is not announced yet